AU3227000A - Methods of inducing insulin positive progenitor cells - Google Patents

Methods of inducing insulin positive progenitor cells

Info

Publication number
AU3227000A
AU3227000A AU32270/00A AU3227000A AU3227000A AU 3227000 A AU3227000 A AU 3227000A AU 32270/00 A AU32270/00 A AU 32270/00A AU 3227000 A AU3227000 A AU 3227000A AU 3227000 A AU3227000 A AU 3227000A
Authority
AU
Australia
Prior art keywords
methods
progenitor cells
insulin positive
inducing insulin
positive progenitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32270/00A
Inventor
David Kagan
Kevin Pang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ontogeny Inc
Original Assignee
Ontogeny Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ontogeny Inc filed Critical Ontogeny Inc
Publication of AU3227000A publication Critical patent/AU3227000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2235—Secretins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/645—Secretins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU32270/00A 1999-02-10 2000-02-10 Methods of inducing insulin positive progenitor cells Abandoned AU3227000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11957599P 1999-02-10 1999-02-10
US60119575 1999-02-10
PCT/US2000/003422 WO2000047721A2 (en) 1999-02-10 2000-02-10 Methods of inducing insulin positive progenitor cells

Publications (1)

Publication Number Publication Date
AU3227000A true AU3227000A (en) 2000-08-29

Family

ID=22385139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32270/00A Abandoned AU3227000A (en) 1999-02-10 2000-02-10 Methods of inducing insulin positive progenitor cells

Country Status (2)

Country Link
AU (1) AU3227000A (en)
WO (1) WO2000047721A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025306A1 (en) * 2000-01-07 2002-02-28 Baetge Edward E. Methods of increasing the glucose responsiveness of pancreatic ss-cells
US6759039B2 (en) 2000-06-30 2004-07-06 Amcyte, Inc. Culturing pancreatic stem cells having a specified, intermediate stage of development
IL162131A0 (en) 2001-12-07 2005-11-20 Geron Corp Islet cells from human embryonic stem cells
US20030109038A1 (en) 2001-12-07 2003-06-12 Thies R. Scott Chondrocyte precursors derived from human embryonic stem cells
US7101546B2 (en) 2001-12-21 2006-09-05 Amcyte, Inc. In situ maturation of cultured pancreatic stem cells having a specified, intermediate stage of development
US20040115226A1 (en) * 2002-12-12 2004-06-17 Wenji Li Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
US8415153B2 (en) 2006-06-19 2013-04-09 Geron Corporation Differentiation and enrichment of islet-like cells from human pluripotent stem cells
MX2012007026A (en) * 2009-12-18 2013-03-18 Joslin Diabetes Center Inc Beta-cell replication promoting compounds and methods of their use.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK371079A (en) * 1978-09-28 1980-03-29 Nordisk Insulinlab THERAPEUTIC ACTIVE POLYPEPTIDES OR ACID ADDITION SALTS THEREOF AND PROCEDURES FOR THE PREPARATION OF SUCH RELATIONSHIP
JPS58140024A (en) * 1982-02-15 1983-08-19 Eisai Co Ltd Purification method of secretin
JPH06133731A (en) * 1992-10-23 1994-05-17 Zenetsukusu Kk Diet food

Also Published As

Publication number Publication date
WO2000047721A3 (en) 2001-01-25
WO2000047721A2 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
AU5731400A (en) Methods of preparing electrochemical cells
AU5934600A (en) Ring electrode with porous member
AU1796601A (en) Methods of preparing electrochemical cells
AU2134501A (en) Life support oxygen concentrator
AU3706700A (en) Positively charged membrane
AU3867400A (en) Methods of using bioelastomers
AU1269601A (en) Fungamyl-like alpha-amylase variants
AU1803601A (en) Methods and compositions for the introduction of molecules into cells
AUPQ147799A0 (en) Mesenchymal precursor cell
AU6864600A (en) Fuel cell
AU4248000A (en) Methods of use of the taci/taci-l interaction
AU2919001A (en) Syringe
AU1236801A (en) Activation of hcv-specific t cells
AU3376400A (en) Negatively charged membrane
AU5003600A (en) Charged membrane
AU6406300A (en) Personal digital assistant with multiple displays
AU2003221173A1 (en) Placenta-origin mesenchymal cells and medicinal use thereof
AU2001264763A1 (en) Human mesenchymal progenitor cell
AU2880400A (en) Tnf-related proteins
AU5043600A (en) Battery
AUPP938799A0 (en) Electrodes
AU1106401A (en) Battery
AU1796501A (en) Methods of preparing electrochemical cells
AU3227000A (en) Methods of inducing insulin positive progenitor cells
AU5171600A (en) Battery

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase